Deep-Vein Thrombosis

Study shows DVT preventative treatment not implemented in high-risk patients

Published in Drug Week, February 13th, 2004

Researchers at Brigham and Women's Hospital (BWH) have found that the majority of patients at risk for deep-vein thrombosis (DVT) and its serious accompaniment, pulmonary embolism (PE), are not receiving preventive treatment.

Despite recent research publicizing the proven benefits of blood thinning drugs and other approaches such as mechanical devices, preventive measures still appear to be significantly underutilized.

The findings are outlined in the January 15 issue of The American Journal of Cardiology.

"We are fortunate that recent advances have afforded us new tools and resources to help prevent DVT, yet our study...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2004-02-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry